The production and regulation of IGF and IGFBPs in human adipose tissue cultures

Growth Hormone and IGF Research

Volumn 22, Issue 6, 2012, Pages 200-205

  Gude, Mette Faurholdt ^a   Frystyk, Jan ^a   Flyvbjerg, Allan ^a   Bruun, Jens Meldgaard ^a   Richelsen, Bjørn ^a   Pedersen, Steen Bønløkke ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Adipose tissue; IGF I; IGF II; IGFBPs; In vitro

Indexed keywords

DEXAMETHASONE; GROWTH HORMONE; INSULIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN BINDING PROTEIN 4; SOMATOMEDIN BINDING PROTEIN 5; SOMATOMEDIN BINDING PROTEIN 6; SOMATOMEDIN C; TUMOR NECROSIS FACTOR ALPHA;

ADIPOSE TISSUE; ADULT; ARTICLE; CULTURE MEDIUM; FEMALE; GENE EXPRESSION; HORMONE SYNTHESIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOASSAY; INCUBATION TIME; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; PROTEIN SECRETION; QUANTITATIVE ASSAY; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY MECHANISM; SUBCUTANEOUS FAT; TISSUE CULTURE; WESTERN BLOTTING;

ADIPOSE TISSUE; ADULT; CELLS, CULTURED; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 4; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; INTERLEUKIN-1BETA; RNA, MESSENGER;

EID: 84868488079     PISSN: 10966374     EISSN: 15322238     Source Type: Journal    
DOI: 10.1016/j.ghir.2012.09.004     Document Type: Article

References (43)

1. Badman M.K., Flier J.S. The adipocyte as an active participant in energy balance and metabolism. Gastroenterology 2007, 132:2103-2115.
2. Fruhbeck G., Gomez-Ambrosi J., Muruzabal F.J., Burrell M.A. The adipocyte: a model for integration of endocrine and metabolic signaling in energy metabolism regulation. Am. J. Physiol. Endocrinol. Metab. 2001, 280:E827-E847.
3. LeRoith D., Yakar S. Mechanisms of disease: metabolic effects of growth hormone and insulin-like growth factor 1. Nat. Clin. Pract. Endocrinol. Metab. 2007, 3:302-310.
4. LeRoith D., Novosyadlyy R., Gallagher E.J., Lann D., Vijayakumar A., Yakar S. Obesity and type 2 diabetes are associated with an increased risk of developing cancer and a worse prognosis; epidemiological and mechanistic evidence. Exp. Clin. Endocrinol. Diabetes 2008, 116(Suppl. 1):S4-S6.
5. van Kruijsdijk R.C., van der Wall E., Visseren F.L. Obesity and cancer: the role of dysfunctional adipose tissue. Cancer Epidemiol. Biomarkers Prev. 2009, 18:2569-2578.
6. Hajer G.R., van Haeften T.W., Visseren F.L. Adipose tissue dysfunction in obesity, diabetes, and vascular diseases. Eur. Heart J. 2008, 29:2959-2971.
7. Scavo L.M., Karas M., Murray M., LeRoith D. Insulin-like growth factor-I stimulates both cell growth and lipogenesis during differentiation of human mesenchymal stem cells into adipocytes. J. Clin. Endocrinol. Metab. 2004, 89:3543-3553.
8. Chan S.S., Twigg S.M., Firth S.M., Baxter R.C. Insulin-like growth factor binding protein-3 leads to insulin resistance in adipocytes. J. Clin. Endocrinol. Metab. 2005, 90:6588-6595.
9. Boney C.M., Moats-Staats B.M., Stiles A.D., D'Ercole A.J. Expression of insulin-like growth factor-I (IGF-I) and IGF-binding proteins during adipogenesis. Endocrinology 1994, 135:1863-1868.
10. Smith P.J., Wise L.S., Berkowitz R., Wan C., Rubin C.S. Insulin-like growth factor-I is an essential regulator of the differentiation of 3T3-L1 adipocytes. J. Biol. Chem. 1988, 263:9402-9408.
11. Baxter R.C., Twigg S.M. Actions of IGF binding proteins and related proteins in adipose tissue. Trends Endocrinol. Metab. 2009, 20:499-505.
12. Jones J.I., Clemmons D.R. Insulin-like growth factors and their binding proteins: biological actions. Endocr. Rev. 1995, 16:3-34.
13. Firth S.M., Baxter R.C. Cellular actions of the insulin-like growth factor binding proteins. Endocr. Rev. 2002, 23:824-854.
14. Kloting N., Koch L., Wunderlich T., Kern M., Ruschke K., Krone W., Bruning J.C., Bluher M. Autocrine IGF-1 action in adipocytes controls systemic IGF-1 concentrations and growth. Diabetes 2008, 57:2074-2082.
15. Bluher S., Kratzsch J., Kiess W. Insulin-like growth factor I, growth hormone and insulin in white adipose tissue. Best Pract. Res. Clin. Endocrinol. Metab. 2005, 19:577-587.
16. Bruun J.M., Pedersen S.B., Kristensen K., Richelsen B. Effects of pro-inflammatory cytokines and chemokines on leptin production in human adipose tissue in vitro. Mol. Cell. Endocrinol. 2002, 190:91-99.
17. Blum W.F., Ranke M.B., Bierich J.R. A specific radioimmunoassay for insulin-like growth factor II: the interference of IGF binding proteins can be blocked by excess IGF-I. Acta Endocrinol. (Copenh.) 1988, 118:374-380.
18. Frystyk J., Dinesen B., Ørskov H. Non-competitive time-resolved immunofluorometric assays for determination of human insulin-like growth factor I and II. Growth Regul. 1995, 5:169-176.
19. Hossenlopp P., Seurin D., Segovia-Quinson B., Hardouin S., Binoux M. Analysis of serum insulin-like growth factor binding proteins using western blotting: use of the method for titration of the binding proteins and competitive binding studies. Anal. Biochem. 1986, 154:138-143.
20. Krassas G.E., Pontikides N., Kaltsas T., Dumas A., Frystyk J., Chen J.W., Flyvbjerg A. Free and total insulin-like growth factor (IGF)-I, -II, and IGF binding protein-1, -2, and -3 serum levels in patients with active thyroid eye disease. J. Clin. Endocrinol. Metab. 2003, 88:132-135.
21. Bruun J.M., Pedersen S.B., Richelsen B. Interleukin-8 production in human adipose tissue. inhibitory effects of anti-diabetic compounds, the thiazolidinedione ciglitazone and the biguanide metformin. Horm. Metab. Res. 2000, 32:537-541.
22. Giudice L.C., Dsupin B.A., Gargosky S.E., Rosenfeld R.G., Irwin J.C. The insulin-like growth factor system in human peritoneal fluid: its effects on endometrial stromal cells and its potential relevance to endometriosis. J. Clin. Endocrinol. Metab. 1994, 79:1284-1293.
23. Flyvbjerg A., Mogensen O., Mogensen B., Nielsen O.S. Elevated serum insulin-like growth factor-binding protein 2 (IGFBP-2) and decreased IGFBP-3 in epithelial ovarian cancer: correlation with cancer antigen 125 and tumor-associated trypsin inhibitor. J. Clin. Endocrinol. Metab. 1997, 82:2308-2313.
24. Cingel-Ristic V., van Neck J.W., Frystyk J., Drop S.L., Flyvbjerg A. Administration of human insulin-like growth factor-binding protein-1 increases circulating levels of growth hormone in mice. Endocrinology 2004, 145:4401-4407.
25. Wabitsch M., Heinze E., Debatin K.M., Blum W.F. IGF-I and IGFBP-3-expression in cultured human preadipocytes and adipocytes. Horm. Metab. Res. 2000, 32:555-559.
26. Gardan D., Mourot J., Louveau I. Decreased expression of the IGF-II gene during porcine adipose cell differentiation. Mol. Cell. Endocrinol. 2008, 292:63-68.
27. Hausman G.J., Poulos S.P., Richardson R.L., Barb C.R., Andacht T., Kirk H.C., Mynatt R.L. Secreted proteins and genes in fetal and neonatal pig adipose tissue and stromal-vascular cells. J. Anim. Sci. 2006, 84:1666-1681.
28. Yu H., Mistry J., Nicar M.J., Khosravi M.J., Diamandis A., Van Doorn J., Juul A. Insulin-like growth factors (IGF-I, free IGF-I and IGF-II) and insulin-like growth factor binding proteins (IGFBP-2, IGFBP-3, IGFBP-6, and ALS) in blood circulation. J. Clin. Lab. Anal. 1999, 13:166-172.
29. Frystyk J., Skjærbæk C., Vestbo E., Fisker S., Ørskov H. Circulating levels of free insulin-like growth factors in obese subjects: the impact of type 2 diabetes. Diabetes Metab. Res. Rev. 1999, 15:314-322.
30. Tchoukalova Y.D., Nathanielsz P.W., Conover C.A., Smith S.R., Ravussin E. Regional variation in adipogenesis and IGF regulatory proteins in the fetal baboon. Biochem. Biophys. Res. Commun. 2009, 380:679-683.
31. Peter M.A., Winterhalter K.H., Boni-Schnetzler M., Froesch E.R., Zapf J. Regulation of insulin-like growth factor-I (IGF-I) and IGF-binding proteins by growth hormone in rat white adipose tissue. Endocrinology 1993, 133:2624-2631.
32. Chen N.X., Hausman G.J., Wright J.T. Hormonal regulation of insulin-like growth factor binding proteins and insulin-like growth factor I (IGF-I) secretion in porcine stromal-vascular cultures. J. Anim. Sci. 1996, 74:2369-2375.
33. Vikman K., Isgaard J., Eden S. Growth hormone regulation of insulin-like growth factor-I mRNA in rat adipose tissue and isolated rat adipocytes. J. Endocrinol. 1991, 131:139-145.
34. Hausman G.J., Richardson R.L., Simmen F.A. Expression of insulin-like growth factor binding proteins (IGFBPs) before and during the hormone sensitive period of adipose tissue development in the fetal pig. Growth Dev. Aging 2000, 64:51-67.
35. Tzanavari T., Giannogonas P., Karalis K.P. TNF-alpha and obesity. Curr. Dir. Autoimmun. 2010, 11:145-156.
36. Cawthorn W.P., Sethi J.K. TNF-alpha and adipocyte biology. FEBS Lett. 2008, 582:117-131.
37. O'Connor J.C., McCusker R.H., Strle K., Johnson R.W., Dantzer R., Kelley K.W. Regulation of IGF-I function by proinflammatory cytokines: at the interface of immunology and endocrinology. Cell. Immunol. 2008, 252:91-110.
38. Maury E., Brichard S.M. Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome. Mol. Cell. Endocrinol. 2010, 314:1-16.
39. Kras K.M., Hausman D.B., Martin R.J. Tumor necrosis factor-alpha stimulates cell proliferation in adipose tissue-derived stromal-vascular cell culture: promotion of adipose tissue expansion by paracrine growth factors. Obes. Res. 2000, 8:186-193.
40. Sieuwerts A.M., Klijn J.G., Foekens J.A. Insulin-like growth factor 1 (IGF-1) and urokinase-type plasminogen activator (uPA) are inversely related in human breast fibroblasts. Mol. Cell. Endocrinol. 1999, 154:179-185.
41. Kveiborg M., Flyvbjerg A., Rattan S.I., Kassem M. Changes in the insulin-like growth factor-system may contribute to in vitro age-related impaired osteoblast functions. Exp. Gerontol. 2000, 35:1061-1074.
42. Rutanen E.M., Nyman T., Lehtovirta P., Ammala M., Pekonen F. Suppressed expression of insulin-like growth factor binding protein-1 mRNA in the endometrium: a molecular mechanism associating endometrial cancer with its risk factors. Int. J. Cancer 1994, 59:307-312.
43. Bushman T.L., Kuemmerle J.F. IGFBP-3 and IGFBP-5 production by human intestinal muscle: reciprocal regulation by endogenous TGF-beta1. Am. J. Physiol. 1998, 275:G1282-G1290.